Skip to main content

Let’s talk about something that sounds simple… but isn’t.

You hear about lower drug prices.
You hear about something like “TrumpRx.”
You think:

“Well great. I’ll just order my meds from trumprx.gov and skip the pharmacy.”

That sounds efficient.

It’s also where things can get messy.

So let’s break this down the way normal humans talk about it.


First — The Guardrail Nobody Should Forget

Starting in 2026, the most you can pay out-of-pocket for covered prescription drugs under Medicare Part D is $2,100 for the entire year.

That’s your ceiling.

Once you hit $2,100 in covered drug costs:

You’re done paying for covered meds for the rest of that calendar year.

That matters more than almost any headline.


So… Should You Use TrumpRx.gov Instead of Your Medicare Plan?

Short answer:

Usually, no.

Long answer:

It depends — but most Medicare beneficiaries are better off staying inside their drug plan.

Let’s walk through both sides.


Why Someone Might Consider Using TrumpRx.gov

There are a few scenarios where someone might be tempted:

1. A Drug Isn’t Covered on Their Plan

If a medication isn’t on your formulary, you may be paying full price anyway.

In that case, comparing outside pricing could make sense.


2. A Cheap Generic Is Dramatically Lower in Cash Pricing

Sometimes a $12 generic is cheaper cash than running it through insurance.

If:

  • It’s a short-term medication
  • You’re nowhere near the $2,100 cap
  • And it won’t affect your long-term costs

Then comparing options isn’t crazy.


3. Very Low Prescription Usage

If someone takes:

  • One inexpensive medication
  • Has minimal annual drug spending
  • And will never come close to $2,100

They might shop around occasionally without major downside.

But now let’s talk about why this often backfires.


Why Most Medicare Beneficiaries Should NOT Bypass Their Plan

Here’s the big issue.

When you buy medications outside of:

  • Medicare Part D
  • Medicare Advantage

Those purchases typically:

  • ❌ Do NOT count toward your deductible
  • ❌ Do NOT count toward your annual out-of-pocket maximum
  • ❌ Do NOT move you closer to the $2,100 cap

So if you later have a year where:

  • You need an expensive drug
  • You start chemotherapy
  • You require specialty medication

You’ve lost the tracking benefit.

And at that point, the cap becomes very valuable.


The Protection Is Worth More Than the Discount

Here’s the reality most people miss:

The $2,100 cap in 2026 is catastrophic protection.

It protects you from:

  • Surprise high-cost years
  • Specialty drug exposure
  • Unexpected diagnosis

If you step outside the system chasing a slightly cheaper monthly cost, you may lose that long-term protection.

That’s like canceling your homeowner’s insurance because you haven’t had a fire lately.

It feels smart… until it isn’t.


Also — Most Policy Changes Flow Through Medicare Anyway

Even if drug pricing reforms expand under new initiatives, those changes are typically implemented through:

  • Centers for Medicare & Medicaid Services
  • Existing Part D contracts
  • Medicare Advantage carrier structures

Not by replacing your Medicare card with a different website.


The Practical Approach

Instead of asking:

“Should I ditch my Medicare drug plan?”

The better question is:

“Should we compare my total annual cost inside my Medicare plan versus outside options?”

That’s a math problem. Not a political one.

And most of the time — especially for Medicare Advantage clients — staying within your plan structure wins because:

  • You keep the $2,100 cap protection
  • You maintain formulary safeguards
  • You avoid coverage disruptions
  • You preserve annual review flexibility

The Bottom Line

TrumpRx discussions are about lowering drug prices.

That’s good.

But Medicare beneficiaries already have a powerful protection built into the system for 2026:

A $2,100 annual out-of-pocket maximum under Part D.

Before bypassing your coverage:

✔ Compare total annual cost
✔ Consider worst-case scenarios
✔ Understand what counts toward the cap
✔ Run the numbers — don’t guess

Because the goal isn’t to chase headlines.

It’s to make sure you’re never surprised at the pharmacy counter… especially in the year you need the protection most.

Cory Carlton
Post by Cory Carlton
Mar 2, 2026 10:42:20 AM
CEO Co-Founder Investment Advisor Representative